Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Lara A. Flatau

Member

Nashville
(615) 742-6284 TEL
(615) 742-0470 FAX

Lara A. Flatau

Member

Nashville
(615) 742-6284 TEL
(615) 742-0470 FAX
Nashville
(615) 742-6284 TEL
(615) 742-0470 FAX

Lara Flatau's practice focuses on mergers and acquisitions as well as regulation, compliance and operational issues for healthcare companies. She provides counsel to a variety of clients in the healthcare industry, including hospitals, skilled nursing, behavioral health, acute care and long-term care facilities, home healthcare agencies, physician practice management companies and healthcare information technology companies, among others.

Her practice includes:

  • Mergers & Acquisitions – Providing counsel in a variety of business transactions, including mergers, acquisitions, combinations and dispositions of hospitals, outpatient service providers and other healthcare companies; conducting due diligence and analysis of joint ventures, mergers and acquisitions from a business and healthcare regulatory perspective; analyzing regulatory requirements and operational impacts related to the purchase and sale of healthcare facilities.
  • Contracting, Regulatory & Operational – Advising clients on regulatory matters, including licensure and issues related to the corporate practice of medicine; assisting clients with various operational agreements, including physician employment and recruitment agreements.

Lara is active in various healthcare organizations including the Nashville Health Care Council and Leadership Health Care. 

Prior to joining Bass, Berry & Sims, Lara practiced at Harwell Howard Hyne Gabbert & Manner, P.C.

Memberships

Nashville Bar Association

Tennessee Bar Association

American Bar Association

Nashville Health Care Council – Leadership Health Care, Membership and Marketing Committee (2014-2015)

American Health Lawyers Association (AHLA)

News

View More

Representative Experience

View More

Publications

View More

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.